NLR family member NLRC5 is a transcriptional regulator of MHC class I genes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 31, 2010, Pages 13794-13799

  Meissner, Torsten B ^a,b   Li, Amy ^a   Biswas, Amlan ^a,b   Lee, Kyoung Hee ^a,b   Liu, Yuen Joyce ^a   Bayir, Erkan ^a   Iliopoulos, Dimitrios ^b   Van Den Elsen, Peter J ^c,d   Kobayashi, Koichi S ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antigen presentation; Class II transactivator; IFN

Indexed keywords

BETA 2 MICROGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NUCLEAR PROTEIN; PROTEIN NLRC5; UNCLASSIFIED DRUG; NLRC5 PROTEIN, HUMAN; SIGNAL PEPTIDE; SMALL INTERFERING RNA;

ARTICLE; CELL NUCLEUS; CYTOSOL; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN LOCALIZATION; UPREGULATION; ACTIVE TRANSPORT; AMINO ACID SEQUENCE; CELL LINE; CHEMISTRY; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; PHYLOGENY; PROMOTER REGION;

MUS;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EID: 77956372057     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1008684107     Document Type: Article

References (43)

1. Pamer E, Cresswell P (1998) Mechanisms of MHC class I - restricted antigen processing. Annu Rev Immunol 16:323-358.
2. Braud VM, Allan DS, McMichael AJ (1999) Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr Opin Immunol 11:100-108.
3. Le Bouteiller P, Solier C (2001) Is antigen presentation the primary function of HLA-G? Microbes Infect 3:323-332.
4. Shastri N, Cardinaud S, Schwab SR, Serwold T, Kunisawa J (2005) All the peptides that fit: The beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol Rev 207:31-41.
5. Peaper DR, Cresswell P (2008) Regulation of MHC class I assembly and peptide binding. Annu Rev Cell Dev Biol 24:343-368.
6. Reith W, Mach B (2001) The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol 19:331-373.
7. van den Elsen PJ, Gobin SJ, van Eggermond MC, Peijnenburg A (1998) Regulation of MHC class I and II gene transcription: Differences and similarities. Immunogenetics 48:208-221.
8. van den Elsen PJ, Peijnenburg A, van Eggermond MC, Gobin SJ (1998) Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol Today 19:308-312.
9. Boss JM, Jensen PE (2003) Transcriptional regulation of the MHC class II antigen presentation pathway. Curr Opin Immunol 15:105-111.
10. Masternak K, et al. (2000) CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev 14:1156-1166.
11. Wilmanski JM, Petnicki-Ocwieja T, Kobayashi KS (2008) NLR proteins: Integral members of innate immunity and mediators of inflammatory diseases. J Leukoc Biol 83:13-30.
12. Ting JP, Willingham SB, Bergstralh DT (2008) NLRs at the intersection of cell death and immunity. Nat Rev Immunol 8:372-379.
13. Beresford GW, Boss JM (2001) CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter. Nat Immunol 2:652-657.
14. DeSandro A, Nagarajan UM, Boss JM (1999) The bare lymphocyte syndrome: Molecular clues to the transcriptional regulation of major histocompatibility complex class II genes. Am J Hum Genet 65:279-286.
15. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B (1994) Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106-109.
16. LeibundGut-Landmann S, et al. (2004) Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes. Eur J Immunol 34:1513-1525.
17. Martin BK, et al. (1997) Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6:591-600.
18. Ting JP, Trowsdale J (2002) Genetic control of MHC class II expression. Cell 109 (Suppl):S21-S33.
19. Bénichou B, Strominger JL (1991) Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc Natl Acad Sci USA 88:4285-4288.
20. Steimle V, Otten LA, Zufferey M, Mach B (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135-146.
21. Chang CH, Guerder S, Hong SC, van Ewijk W, Flavell RA (1996) Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167-178.
22. Itoh-Lindstrom Y, et al. (1999) Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. J Immunol 163:2425-2431.
23. Williams GS, et al. (1998) Mice lacking the transcription factor CIITA - a second look. Int Immunol 10:1957-1967.
24. Cressman DE, Chin KC, Taxman DJ, Ting JP (1999) A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome. Immunity 10:163-171.
25. Spilianakis C, Papamatheakis J, Kretsovali A (2000) Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes. Mol Cell Biol 20:8489-8498.
26. Cressman DE, O'Connor WJ, Greer SF, Zhu XS, Ting JP (2001) Mechanisms of nuclear import and export that control the subcellular localization of class II transactivator. J Immunol 167:3626-3634.
27. Lange A, et al. (2007) Classical nuclear localization signals: Definition, function, and interaction with importin alpha. J Biol Chem 282:5101-5105.
28. Hanson PI, Whiteheart SW (2005) AAA+ proteins: Have engine, will work. Nat Rev Mol Cell Biol 6:519-529.
29. Gobin SJ, Peijnenburg A, Keijsers V, van den Elsen PJ (1997) Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: The ISRE-mediated route and a novel pathway involving CIITA. Immunity 6:601-611.
30. Girdlestone J (2000) Synergistic induction of HLA class I expression by RelA and CIITA. Blood 95:3804-3808.
31. Gobin SJ, van Zutphen M, Westerheide SD, Boss JM, van den Elsen PJ (2001) The MHC-specific enhanceosome and its role in MHC class I and beta(2)-microglobulin gene transactivation. J Immunol 167:5175-5184.
32. Chang CH, Fontes JD, Peterlin M, Flavell RA (1994) Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 180:1367-1374.
33. Kuenzel S, et al. (2010) The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses. J Immunol 184:1990-2000.
34. Nickerson K, et al. (2001) Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity. J Biol Chem 276:19089-19093.
35. Wright KL, et al. (1998) CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc Natl Acad Sci USA 95:6267-6272.
36. Bewry NN, Bolick SC, Wright KL, Harton JA (2007) GTP-dependent recruitment of CIITA to the class II major histocompatibility complex promoter. J Biol Chem282:26178-26184.
37. Cui J, et al. (2010) NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 141:483-496.
38. Muhlethaler-MottetA, Di Berardino W, Otten LA, Mach B (1998) Activation of theMHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity 8:157-166.
39. Piskurich JF, Wang Y, Linhoff MW, White LC, Ting JP (1998) Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene. J Immunol 160:233-240.
40. Piskurich JF, Linhoff MW, Wang Y, Ting JP (1999) Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta. Mol Cell Biol 19:431-440.
41. Chin KC, Li GG, Ting JP (1997) Importance of acidic, proline/serine/ threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: Generation of transdominant-negative mutants. Proc Natl Acad Sci USA 94:2501-2506.
42. Petnicki-Ocwieja T, et al. (2009) Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci USA 106:15813-15818.
43. Iliopoulos D, Hirsch HA, Struhl K (2009) An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139:693-706.